Cargando…
Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia
BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593689/ https://www.ncbi.nlm.nih.gov/pubmed/34795539 http://dx.doi.org/10.2147/HMER.S337817 |
_version_ | 1784599803973337088 |
---|---|
author | Ayelign, Meseret Aynalem, Melak Berhane, Nega |
author_facet | Ayelign, Meseret Aynalem, Melak Berhane, Nega |
author_sort | Ayelign, Meseret |
collection | PubMed |
description | BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed to determine the seroprevalence and associated factors of HBV and HCV among HIV-positive study participants. METHODS: A cross-sectional study was conducted among 81 individuals, and a non-randomized purposive sampling technique was used. From each study participant, sociodemographic and clinical data were gathered by using a pretested questionnaire and data collection sheet, respectively. Further, a venous blood sample was collected for viral load count, and HBV and HCV determination. To keep the quality of test results, commercially prepared quality control samples were used. The data were entered to EPI-Info version 7 and analyzed by using SPSS version 20. The descriptive data were summarized in percentages, median, and IQR. Logistic regression was analyzed to determine associated factors. To say the data were statistically significant, the p-values should be less than 0.05. RESULTS: A total of 81 study participants were included. Of them, 56.8% (46/81) and 67.9% (55/81) were female and urban residents, respectively. The prevalence of hepatitis co-infection was 21% (95% CI: 17%, 23%). Further, the prevalence of HBV/HIV and HCV/HIV was 13.5% (95% CI: 10.5%, 16.5%) and 8.6% (95% CI: 5.6%, 11.6%), respectively. Wise use of highly active antiretroviral therapy (HAART) 0.01 (0.00, 0.213) was a preventive factor to hepatitis infection. CONCLUSION AND RECOMMENDATION: The HBV and HCV co-infection among HIV-positive patients was a significant public health concern. Also, having wise use of HAART can reduce exposure to hepatitis co-infection. Therefore, clear strategies on hepatitis screening and wise use of HAART to HIV would be critical. |
format | Online Article Text |
id | pubmed-8593689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85936892021-11-17 Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia Ayelign, Meseret Aynalem, Melak Berhane, Nega Hepat Med Original Research BACKGROUND: Viral infections are the most common diseases. Of them, human immunodeficiency virus (HIV), hepatitis B viruses (HBV), and hepatitis C viruses (HCV) are common. When HBV or HCV becomes co-morbid with HIV, they lead to severe forms of a disease and rapid death. OBJECTIVE: This study aimed to determine the seroprevalence and associated factors of HBV and HCV among HIV-positive study participants. METHODS: A cross-sectional study was conducted among 81 individuals, and a non-randomized purposive sampling technique was used. From each study participant, sociodemographic and clinical data were gathered by using a pretested questionnaire and data collection sheet, respectively. Further, a venous blood sample was collected for viral load count, and HBV and HCV determination. To keep the quality of test results, commercially prepared quality control samples were used. The data were entered to EPI-Info version 7 and analyzed by using SPSS version 20. The descriptive data were summarized in percentages, median, and IQR. Logistic regression was analyzed to determine associated factors. To say the data were statistically significant, the p-values should be less than 0.05. RESULTS: A total of 81 study participants were included. Of them, 56.8% (46/81) and 67.9% (55/81) were female and urban residents, respectively. The prevalence of hepatitis co-infection was 21% (95% CI: 17%, 23%). Further, the prevalence of HBV/HIV and HCV/HIV was 13.5% (95% CI: 10.5%, 16.5%) and 8.6% (95% CI: 5.6%, 11.6%), respectively. Wise use of highly active antiretroviral therapy (HAART) 0.01 (0.00, 0.213) was a preventive factor to hepatitis infection. CONCLUSION AND RECOMMENDATION: The HBV and HCV co-infection among HIV-positive patients was a significant public health concern. Also, having wise use of HAART can reduce exposure to hepatitis co-infection. Therefore, clear strategies on hepatitis screening and wise use of HAART to HIV would be critical. Dove 2021-11-11 /pmc/articles/PMC8593689/ /pubmed/34795539 http://dx.doi.org/10.2147/HMER.S337817 Text en © 2021 Ayelign et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ayelign, Meseret Aynalem, Melak Berhane, Nega Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title | Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title_full | Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title_fullStr | Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title_full_unstemmed | Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title_short | Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia |
title_sort | hepatitis and hiv co-infection at university of gondar specialized referral hospital: northwest ethiopia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593689/ https://www.ncbi.nlm.nih.gov/pubmed/34795539 http://dx.doi.org/10.2147/HMER.S337817 |
work_keys_str_mv | AT ayelignmeseret hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia AT aynalemmelak hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia AT berhanenega hepatitisandhivcoinfectionatuniversityofgondarspecializedreferralhospitalnorthwestethiopia |